Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2

Cell Discov. 2022 May 10;8(1):43. doi: 10.1038/s41421-022-00411-4.

Yifan Lin^#¹, Jing Sun^#², Xuezhi Cao^#³, Xiuye Wang³, Xi Chen⁴, Hairong Xu¹, Jincun Zhao^{5

6}, Yang-Xin Fu⁷, Hua Peng^{8

9}

¹ Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
² State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
³ Guangzhou Laboratory and Bioland Laboratory, Guangzhou, Guangdong, China.
⁴ LivzonBio Inc., Zhuhai, Guangdong, China.
⁵ State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. zhaojincun@gird.cn.
⁶ Guangzhou Laboratory and Bioland Laboratory, Guangzhou, Guangdong, China. zhaojincun@gird.cn.
⁷ Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China. yangxinfu@tsinghua.edu.cn.
⁸ Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. hpeng@moon.ibp.ac.cn.
⁹ Guangzhou Laboratory and Bioland Laboratory, Guangzhou, Guangdong, China. hpeng@moon.ibp.ac.cn.

^# Contributed equally.

No abstract available

Publication types